However, there was no relevant expression of SFRP1 and BUB1B genes detected in the validation set B. Due to the high lethality of ovarian cancer, we took the potential genes obtained from validation set A and validation set B. Thus, altogether, 9 diagnostic genes were obtained. This evidence concerns the gene BUB1B and ovarian carcinoma.